Published in Psychiatry Clin Neurosci on February 01, 2010
Digitalis intoxication induced by paroxetine co-administration. Lancet (2006) 2.01
Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat Genet (2004) 1.98
Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia. J Clin Psychopharmacol (2010) 1.81
Effect of dose timing in relation to food intake on systemic exposure to blonanserin. Eur J Clin Pharmacol (2010) 1.47
Association between major Multidrug Resistance 1 (MDR1) gene polymorphisms and plasma concentration of prolactin during risperidone treatment in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.38
Mutations of neuronal voltage-gated Na+ channel alpha 1 subunit gene SCN1A in core severe myoclonic epilepsy in infancy (SMEI) and in borderline SMEI (SMEB). Epilepsia (2004) 1.24
Defective function of GABA-containing synaptic vesicles in mice lacking the AP-3B clathrin adaptor. J Cell Biol (2004) 1.22
Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes. Br J Clin Pharmacol (2005) 1.21
Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am J Hum Genet (2005) 1.11
Severe myoclonic epilepsy in infancy: clinical analysis and relation to SCN1A mutations in a Japanese cohort. Adv Neurol (2005) 1.10
Metabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes. Br J Clin Pharmacol (2003) 1.08
Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes. Br J Clin Pharmacol (2006) 1.06
Mutational analysis of CACNA1G in idiopathic generalized epilepsy. Mutation in brief #962. Online. Hum Mutat (2007) 1.03
Prevalence of metabolic syndrome among patients with schizophrenia in Japan. Schizophr Res (2010) 1.02
Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes. Br J Clin Pharmacol (2004) 1.01
Genetics of idiopathic epilepsies. Epilepsia (2005) 0.97
Staphylococcal enterotoxin induces emesis through increasing serotonin release in intestine and it is downregulated by cannabinoid receptor 1. Cell Microbiol (2007) 0.97
The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics. Clin Pharmacokinet (2005) 0.97
Liquid chromatographic determination of fexofenadine in human plasma with fluorescence detection. J Pharm Biomed Anal (2004) 0.96
Gender differences in factors associated with suicidal ideation and depressive symptoms among middle-aged workers in Japan. Ind Health (2012) 0.94
The genetics of febrile seizures and related epilepsy syndromes. Brain Dev (2003) 0.94
Nucleotide changes in the translated region of SCN5A from Japanese patients with Brugada syndrome and control subjects. Life Sci (2003) 0.94
Microchromosomal deletions involving SCN1A and adjacent genes in severe myoclonic epilepsy in infancy. Epilepsia (2008) 0.94
Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations. Eur J Clin Pharmacol (2007) 0.93
Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients. J Psychopharmacol (2011) 0.90
Patients with a sodium channel alpha 1 gene mutation show wide phenotypic variation. Epilepsy Res (2007) 0.90
The difference in Mismatch negativity between the acute and post-acute phase of schizophrenia. Biol Psychol (2002) 0.89
Age-dependent modulation of hippocampal excitability by KCNQ-channels. Epilepsy Res (2003) 0.89
Detection of Corynebacterium kutscheri from the oral cavity of rats. Exp Anim (2002) 0.89
Remapping and mutation analysis of benign adult familial myoclonic epilepsy in a Japanese pedigree. J Hum Genet (2011) 0.88
Mortality in Dravet syndrome: search for risk factors in Japanese patients. Epilepsia (2011) 0.88
Effects of ryanodine receptor activation on neurotransmitter release and neuronal cell death following kainic acid-induced status epilepticus. Epilepsy Res (2005) 0.88
Different patterns of dipole source localization in gelastic seizure with or without a sense of mirth. Neurosci Res (2002) 0.88
Determination of lansoprazole and two of its metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography: application to measuring CYP2C19 activity. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.88
Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra-short-acting beta1-blocker. Drugs R D (2005) 0.87
Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome. Am J Med Genet B Neuropsychiatr Genet (2003) 0.87
Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.87
Mutation (Ser284Leu) of neuronal nicotinic acetylcholine receptor alpha 4 subunit associated with frontal lobe epilepsy causes faster desensitization of the rat receptor expressed in oocytes. Epilepsy Res (2002) 0.87
Retrospective multiinstitutional study of the prevalence of early death in Dravet syndrome. Epilepsia (2011) 0.87
Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers. Xenobiotica (2010) 0.87
Inverse correlation between clinical response to paroxetine and plasma drug concentration in patients with major depressive disorders. Hum Psychopharmacol (2011) 0.86
Prevalence of SCN1A mutations in children with suspected Dravet syndrome and intractable childhood epilepsy. Epilepsy Res (2012) 0.86
The effects of a two-hour judo training session on the neutrophil immune functions in university judoists. Luminescence (2008) 0.86
No association between dietary patterns and depressive symptoms among a community-dwelling population in Japan. Ann Gen Psychiatry (2012) 0.86
No association between bone mass and prolactin levels among patients with schizophrenia. Hum Psychopharmacol (2011) 0.86
Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.86
Effect of age and disease on bone mass in Japanese patients with schizophrenia. Ann Gen Psychiatry (2012) 0.85
A de novo KCNQ2 mutation detected in non-familial benign neonatal convulsions. Brain Dev (2008) 0.85
Comparison of ankle-brachial pressure index and pulse wave velocity as markers of cognitive function in a community-dwelling population. BMC Psychiatry (2010) 0.85
Effects of CYP2D6 genotypes on plasma concentrations of risperidone and enantiomers of 9-hydroxyrisperidone in Japanese patients with schizophrenia. J Clin Pharmacol (2003) 0.85
Genetic abnormalities underlying familial epilepsy syndromes. Brain Dev (2002) 0.85
Effects of interleukin-1beta on hippocampal glutamate and GABA releases associated with Ca2+-induced Ca2+ releasing systems. Epilepsy Res (2006) 0.85
Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: in vivo evidence of involvement of P-glycoprotein in risperidone disposition. Clin Pharmacol Ther (2005) 0.85
Effect of grapefruit juice in relation to human pharmacokinetic study. Curr Clin Pharmacol (2006) 0.85
Sex-specific effects of subjective memory complaints with respect to cognitive impairment or depressive symptoms. Psychiatry Clin Neurosci (2014) 0.84
Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia. Neuropsychiatr Dis Treat (2013) 0.84
Neuroleptic malignant syndrome induced by lamotrigine. Clin Neuropharmacol (2013) 0.84
Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine. Br J Clin Pharmacol (2005) 0.84
Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia. Ann Gen Psychiatry (2011) 0.84